HL7 FHIR Implementation Guide - New Zealand Formulary/NZULM IG
0.1.0 - ci-build

HL7 FHIR Implementation Guide - New Zealand Formulary/NZULM IG, published by New Zealand Medicines Formulary LP. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/HL7NZ/nzf/ and changes regularly. See the Directory of published versions

ValueSet: ATC codes

Summary

Defining URL:https://nzhts.digital.health.nz/fhir/ValueSet/atc-code
Version:0.1.0
Name:AtcCodes
Title:ATC codes
Status:Active as of 2021-09-07T23:01:56+00:00
Definition:

ATC Codes

Publisher:New Zealand Medicines Formulary LP
Source Resource:XML / JSON / Turtle

References

Logical Definition (CLD)

 

Expansion

This value set contains 334 concepts

Expansion based on http://www.whocc.no/atc version January 2020

All codes in this table are from the system http://www.whocc.no/atc

CodeDisplayDefinition
AALIMENTARY TRACT AND METABOLISM
A01STOMATOLOGICAL PREPARATIONS
A01ASTOMATOLOGICAL PREPARATIONS
A01AACaries prophylactic agents
A01AA01sodium fluoride
A01AA02sodium monofluorophosphate
A01AA03olaflur
A01AA04stannous fluoride
A01AA30combinations
A01AA51sodium fluoride, combinations
A01ABAntiinfectives and antiseptics for local oral treatment
A01AB02hydrogen peroxide
A01AB03chlorhexidine
A01AB04amphotericin B
A01AB05polynoxylin
A01AB06domiphen
A01AB07oxyquinoline
A01AB08neomycin
A01AB09miconazole
A01AB10natamycin
A01AB11various
A01AB12hexetidine
A01AB13tetracycline
A01AB14benzoxonium chloride
A01AB15tibezonium iodide
A01AB16mepartricin
A01AB17metronidazole
A01AB18clotrimazole
A01AB19sodium perborate
A01AB21chlortetracycline
A01AB22doxycycline
A01AB23minocycline
A01ACCorticosteroids for local oral treatment
A01AC01triamcinolone
A01AC02dexamethasone
A01AC03hydrocortisone
A01AC54prednisolone, combinations
A01ADOther agents for local oral treatment
A01AD01epinephrine
A01AD02benzydamine
A01AD05acetylsalicylic acid
A01AD06adrenalone
A01AD07amlexanox
A01AD08becaplermin
A01AD11various
A02DRUGS FOR ACID RELATED DISORDERS
A02AANTACIDS
A02AAMagnesium compounds
A02AA01magnesium carbonate
A02AA02magnesium oxide
A02AA03magnesium peroxide
A02AA04magnesium hydroxide
A02AA05magnesium silicate
A02AA10combinations
A02ABAluminium compounds
A02AB01aluminium hydroxide
A02AB02algeldrate
A02AB03aluminium phosphate
A02AB04dihydroxialumini sodium carbonate
A02AB05aluminium acetoacetate
A02AB06aloglutamol
A02AB07aluminium glycinate
A02AB10combinations
A02ACCalcium compounds
A02AC01calcium carbonate
A02AC02calcium silicate
A02AC10combinations
A02ADCombinations and complexes of aluminium, calcium and magnesium compounds
A02AD01ordinary salt combinations
A02AD02magaldrate
A02AD03almagate
A02AD04hydrotalcite
A02AD05almasilate
A02AFAntacids with antiflatulents
A02AF01magaldrate and antiflatulents
A02AF02ordinary salt combinations and antiflatulents
A02AGAntacids with antispasmodics
A02AHAntacids with sodium bicarbonate
A02AXAntacids, other combinations
A02BDRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BAH2-receptor antagonists
A02BA01cimetidine
A02BA02ranitidine
A02BA03famotidine
A02BA04nizatidine
A02BA05niperotidine
A02BA06roxatidine
A02BA07ranitidine bismuth citrate
A02BA08lafutidine
A02BA51cimetidine, combinations
A02BA53famotidine, combinations
A02BBProstaglandins
A02BB01misoprostol
A02BB02enprostil
A02BCProton pump inhibitors
A02BC01omeprazole
A02BC02pantoprazole
A02BC03lansoprazole
A02BC04rabeprazole
A02BC05esomeprazole
A02BC06dexlansoprazole
A02BC07dexrabeprazole
A02BC53lansoprazole, combinations
A02BC54rabeprazole, combinations
A02BDCombinations for eradication of Helicobacter pylori
A02BD01omeprazole, amoxicillin and metronidazole
A02BD02lansoprazole, tetracycline and metronidazole
A02BD03lansoprazole, amoxicillin and metronidazole
A02BD04pantoprazole, amoxicillin and clarithromycin
A02BD05omeprazole, amoxicillin and clarithromycin
A02BD06esomeprazole, amoxicillin and clarithromycin
A02BD07lansoprazole, amoxicillin and clarithromycin
A02BD08bismuth subcitrate, tetracycline and metronidazole
A02BD09lansoprazole, clarithromycin and tinidazole
A02BD10lansoprazole, amoxicillin and levofloxacin
A02BD11pantoprazole, amoxicillin, clarithromycin and metronidazole
A02BD12rabeprazole, amoxicillin and clarithromycin
A02BD13rabeprazole, amoxicillin and metronidazole
A02BD14vonoprazan, amoxicillin and clarithromycin
A02BD15vonoprazan, amoxicillin and metronidazole
A02BXOther drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02BX01carbenoxolone
A02BX02sucralfate
A02BX03pirenzepine
A02BX04methiosulfonium chloride
A02BX05bismuth subcitrate
A02BX06proglumide
A02BX07gefarnate
A02BX08sulglicotide
A02BX09acetoxolone
A02BX10zolimidine
A02BX11troxipide
A02BX12bismuth subnitrate
A02BX13alginic acid
A02BX14rebamipide
A02BX51carbenoxolone, combinations excl. psycholeptics
A02BX71carbenoxolone, combinations with psycholeptics
A02BX77gefarnate, combinations with psycholeptics
A02XOTHER DRUGS FOR ACID RELATED DISORDERS
A03DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A03ADRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A03AASynthetic anticholinergics, esters with tertiary amino group
A03AA01oxyphencyclimine
A03AA03camylofin
A03AA04mebeverine
A03AA05trimebutine
A03AA06rociverine
A03AA07dicycloverine
A03AA08dihexyverine
A03AA09difemerine
A03AA30piperidolate
A03ABSynthetic anticholinergics, quaternary ammonium compounds
A03AB01benzilone
A03AB02glycopyrronium bromide
A03AB03oxyphenonium
A03AB04penthienate
A03AB05propantheline
A03AB06otilonium bromide
A03AB07methantheline
A03AB08tridihexethyl
A03AB09isopropamide
A03AB10hexocyclium
A03AB11poldine
A03AB12mepenzolate
A03AB13bevonium
A03AB14pipenzolate
A03AB15diphemanil
A03AB16(2-benzhydryloxyethyl)diethyl-methylammonium iodide
A03AB17tiemonium iodide
A03AB18prifinium bromide
A03AB19timepidium bromide
A03AB21fenpiverinium
A03AB53oxyphenonium, combinations
A03ACSynthetic antispasmodics, amides with tertiary amines
A03AC02dimethylaminopropionylphenothiazine
A03AC04nicofetamide
A03AC05tiropramide
A03ADPapaverine and derivatives
A03AD01papaverine
A03AD02drotaverine
A03AD30moxaverine
A03AESerotonin receptor antagonists
A03AE01alosetron
A03AE03cilansetron
A03AXOther drugs for functional gastrointestinal disorders
A03AX01fenpiprane
A03AX02diisopromine
A03AX03chlorbenzoxamine
A03AX04pinaverium
A03AX05fenoverine
A03AX06idanpramine
A03AX07proxazole
A03AX08alverine
A03AX09trepibutone
A03AX10isometheptene
A03AX11caroverine
A03AX12phloroglucinol
A03AX13silicones
A03AX14valethamate
A03AX30trimethyldiphenylpropylamine
A03AX58alverine, combinations
A03BBELLADONNA AND DERIVATIVES, PLAIN
A03BABelladonna alkaloids, tertiary amines
A03BA01atropine
A03BA03hyoscyamine
A03BA04belladonna total alkaloids
A03BBBelladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB01butylscopolamine
A03BB02methylatropine
A03BB03methylscopolamine
A03BB04fentonium
A03BB05cimetropium bromide
A03BB06homatropine methylbromide
A03CANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
A03CASynthetic anticholinergic agents in combination with psycholeptics
A03CA01isopropamide and psycholeptics
A03CA02clidinium and psycholeptics
A03CA03oxyphencyclimine and psycholeptics
A03CA04otilonium bromide and psycholeptics
A03CA05glycopyrronium bromide and psycholeptics
A03CA06bevonium and psycholeptics
A03CA07ambutonium and psycholeptics
A03CA08diphemanil and psycholeptics
A03CA09pipenzolate and psycholeptics
A03CA30emepronium and psycholeptics
A03CA34propantheline and psycholeptics
A03CBBelladonna and derivatives in combination with psycholeptics
A03CB01methylscopolamine and psycholeptics
A03CB02belladonna total alkaloids and psycholeptics
A03CB03atropine and psycholeptics
A03CB04methylhomatropine and psycholeptics
A03CB31hyoscyamine and psycholeptics
A03CCOther antispasmodics in combination with psycholeptics
A03DANTISPASMODICS IN COMBINATION WITH ANALGESICS
A03DASynthetic anticholinergic agents in combination with analgesics
A03DA01tropenzilone and analgesics
A03DA02pitofenone and analgesics
A03DA03bevonium and analgesics
A03DA04ciclonium and analgesics
A03DA05camylofin and analgesics
A03DA06trospium and analgesics
A03DA07tiemonium iodide and analgesics
A03DBBelladonna and derivatives in combination with analgesics
A03DB04butylscopolamine and analgesics
A03DCOther antispasmodics in combination with analgesics
A03EANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS
A03EAAntispasmodics, psycholeptics and analgesics in combination
A03EDAntispasmodics in combination with other drugs
A03FPROPULSIVES
A03FAPropulsives
A03FA01metoclopramide
A03FA02cisapride
A03FA03domperidone
A03FA04bromopride
A03FA05alizapride
A03FA06clebopride
A03FA07itopride
A03FA08cinitapride
A03FA09mosapride
A04ANTIEMETICS AND ANTINAUSEANTS
A04AANTIEMETICS AND ANTINAUSEANTS
A04AASerotonin (5HT3) antagonists
A04AA01ondansetron
A04AA02granisetron
A04AA03tropisetron
A04AA04dolasetron
A04AA05palonosetron
A04AA55palonosetron, combinations
A04ADOther antiemetics
A04AD01scopolamine
A04AD02cerium oxalate
A04AD04chlorobutanol
A04AD05metopimazine
A04AD10dronabinol
A04AD11nabilone
A04AD12aprepitant
A04AD13casopitant
A04AD14rolapitant
A04AD51scopolamine, combinations
A04AD54chlorobutanol, combinations
BBLOOD AND BLOOD FORMING ORGANS
CCARDIOVASCULAR SYSTEM
C10LIPID MODIFYING AGENTS
C10ALIPID MODIFYING AGENTS, PLAIN
C10AAHMG CoA reductase inhibitors
C10AA01simvastatin
DDERMATOLOGICALS
GGENITO URINARY SYSTEM AND SEX HORMONES
G02OTHER GYNECOLOGICALS
G02COTHER GYNECOLOGICALS
G02CXOther gynecologicals
G02CX04Cimicifugae rhizoma
HSYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
JANTIINFECTIVES FOR SYSTEMIC USE
J07VACCINES
J07CBACTERIAL AND VIRAL VACCINES, COMBINED
J07CABacterial and viral vaccines, combined
J07CA02diphtheria-pertussis-poliomyelitis-tetanus
LANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02ENDOCRINE THERAPY
L02BHORMONE ANTAGONISTS AND RELATED AGENTS
L02BGAromatase inhibitors
L02BG03anastrozole
MMUSCULO-SKELETAL SYSTEM
NNERVOUS SYSTEM
N02ANALGESICS
N02AOPIOIDS
N02AANatural opium alkaloids
N02AA01morphine
N02AA02opium
N02AA03hydromorphone
N02AA04nicomorphine
N02AA05oxycodone
N02AA08dihydrocodeine
N02AA10papaveretum
N02AA51morphine, combinations
N02AA53hydromorphone and naloxone
N02AA55oxycodone and naloxone
N02AA56oxycodone and naltrexone
N02AA58dihydrocodeine, combinations
N02AA59codeine, combinations excl. psycholeptics
N02AA79codeine, combinations with psycholeptics
N03ANTIEPILEPTICS
N03AANTIEPILEPTICS
N03AABarbiturates and derivatives
N03AA01methylphenobarbital
N03AA02phenobarbital
N03AA03primidone
N03AA04barbexaclone
N03AA30metharbital
PANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
RRESPIRATORY SYSTEM
SSENSORY ORGANS
VVARIOUS

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
Source The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code